Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Rating of “Buy” from Brokerages
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has earned a consensus rating of “Buy” from the ten ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and two have given a strong buy recommendation to the company. […]
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has earned a consensus rating of “Buy” from the ten ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and two have given a strong buy recommendation to the company. […]
